Literature DB >> 29667560

Can the tea tree oil (Australian native plant: Melaleuca alternifolia Cheel) be an alternative treatment for human demodicosis on skin?

Nelson Siu Kei Lam1, Xin Xin Long1, Robert C Griffin2, Mu-Kai Chen3, James Cg Doery4.   

Abstract

Australian tea tree oil (TTO) and its extract terpinen-4-ol (T4O) are found to be effective in moderating demodex-related diseases. Their possible effects are lowering the mite counts, relieving the demodex-related symptoms and modulating the immune system especially the inflammatory response. This review summarizes the topical treatments of TTO and T4O in human demodicosis, their possible mechanism of actions, side-effects and potential resistance in treating this condition. Although current treatments other than TTO and T4O are relatively effective in controlling the demodex mite population and the related symptoms, more research on the efficacy and drug delivery technology is needed in order to assess its potential as an alternative treatment with minimal side-effect profile, low toxicity and low risk of demodex resistance.

Entities:  

Keywords:  Demodex brevis; Demodex follicularium; Demodicosis; rosacea; tea tree oil; terpinen-4-ol

Mesh:

Substances:

Year:  2018        PMID: 29667560     DOI: 10.1017/S0031182018000495

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  3 in total

1.  Tea tree oil for Demodex blepharitis.

Authors:  Keyur Savla; Jimmy T Le; Andrew D Pucker
Journal:  Cochrane Database Syst Rev       Date:  2020-06-20

Review 2.  Antiparasitic Activity of Tea Tree Oil (TTO) and Its Components against Medically Important Ectoparasites: A Systematic Review.

Authors:  Solomon Abrha Bezabh; Wubshet Tesfaye; Julia K Christenson; Christine F Carson; Jackson Thomas
Journal:  Pharmaceutics       Date:  2022-07-29       Impact factor: 6.525

3.  Successful management of chronic Blepharo-rosacea associated demodex by lid scrub with terpinen-4-ol.

Authors:  Han Y Yin; Sean Tighe; Scheffer Cg Tseng; Anny Ms Cheng
Journal:  Am J Ophthalmol Case Rep       Date:  2021-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.